Regentis Biomaterials Statistics
NYSE: RGNTHealth CareIndustrial SpecialtiesUSD
1.70+0.07 (+4.29%)
Market open · Delayed 15 min · as of Oct 8, 12:15 PM ET
Regentis Biomaterials by the numbers
Regentis Biomaterials has a market capitalization of $11.9 million based on 7.02M shares outstanding. With trailing EPS of $-2.46, Regentis Biomaterials is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.5% below its 50-day average and 49.5% below its 200-day average.
Average daily trading volume is 75.26K shares, or about $127,942 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RGNT valuation vs. peer median
| Metric | RGNT | Peer median | Difference |
|---|---|---|---|
| Market cap | $11.94M | $15.13M | -21% |
| Avg. volume | 75.26K | 141.49K | -47% |
Peer median across 8 companies: CUPR, FGI, HSCS, CLGN, TLIH, LFWD, BBLG, MLSS.
Valuation
- Market cap
- $11.94M
- EPS (TTM)
- $-2.46
- Shares outstanding
- 7.02M
Price and trading
- Previous close
- 1.63
- Open
- 1.69
- Day range
- 1.65 – 1.73
- 52-week range
- 1.23 – 15.50
- Beta
- —
- Volume
- 159.34K
- Average volume
- 75.26K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 11.94M
- Eps
- -2.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.50
- Week52 Low
- 1.23
- Avg Volume
- 75,260.00
- Shares Outstanding
- 7.02M
- Ma50
- 1.94
- Ma200
- 3.36
- Pct From52w High
- -89.03%
- Pct From52w Low
- 37.99%